Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
COVID-19
Jason Slotkin, NPR

FDA grants emergency use authorization for first coronavirus antigen test

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

The antigen test is the third to have received FDA emergency authorization for the coronavirus. The others are a PCR test and an antibody test.
The antigen test is the third to have received FDA emergency authorization for the coronavirus. The others are a PCR test and an antibody test.
Seth Wenig | AP

The U.S. Food and Drug Administration announced Saturday that it has granted its first emergency authorization to a new type of test that can detect the coronavirus, called an antigen test.

The test looks for protein fragments associated with the virus. The sample is collected with a nasal swab and can produce a result in minutes, the FDA said in a statement. The agency notes that compared to already approved genetic testing, the antigen test is cheaper and easier to use and could "potentially scale to test millions of Americans per day" once multiple manufacturers enter the market.

So far, only San Diego-based Quidel Corporation has received authorization for the tests. That authorization was granted late Friday.

Two other types of tests for the coronavirus have received the emergency authorization. One, called a polymerase chain reaction, or PCR test, is a molecular diagnostic tool that identifies the virus's genetic material. The other is an antibody test.

Antigen testing is not without its shortcomings. The FDA notes that this test is less reliable at ruling out infection in patients and that negative results "may need to be confirmed with a PCR test prior to making treatment decisions or to prevent the possible spread of the virus due to a false negative."

"Antigen tests are very specific for the virus, but are not as sensitive as molecular PCR tests," the agency said. "This means that positive results from antigen tests are highly accurate, but there is a higher chance of false negatives, so negative results do not rule out infection."

The FDA says that it expects more antigen tests to be authorized and that they "will play a critical role in the fight against COVID-19."

Copyright 2020 NPR. To see more, visit https://www.npr.org.